Healthcare and Pharmaceuticals
The healthcare and pharmaceuticals industry has grown significantly in the past few years due to an increasing demand for efficient and more effective drugs. The growing number of population and their aging issues, emergence of complex diseases and a plethora of other chronic ailments have increased the investment in the R&D department which is driving the growth of the healthcare and pharmaceuticals market. Currently, the market represents a multibillion dollar industry. Based on diverse therapeutic areas, EMR reports cover numerous market segments which helps the readers to know about the growth indicative factors and the prevailing opportunities in both the developed and emerging markets.
Mammalian polyclonal IgG antibodies are a class of immunoglobulins produced by the immune system of mammals, including humans. They are composed of a mixture of antibodies that recognize different epi...
Small molecule API are active pharmaceutical ingredients with low molecular weight compound and size of nearly 1nm. These small molecule APIs are useful in controlling the biological processes. They c...
Microbiome refers to the population of microorganisms, including bacteria, viruses, and fungi, that exist in the human body. Cancer microbiomes, also known as tumor microbiomes, are a group of microor...
Bioprocess containers are medical containers which are used to contain the medical ingredients that are used to produce biological products. The bioprocess containers are not some ordinary containers ...
The growing geriatric population drives the global adalimumab biosimilar market. Aided by the rising incidence of rheumatoid arthritis and the proliferation of skin disorders, the market is expected t...
The global biologics market is driven by the rising demand for microbial expression systems in the treatment of various chronic diseases. Aided by the increasing research activities to enhance the pro...
The India biosimilar market size reached a value of almost USD 779.92 million in the year 2022. The market is further expected to grow at a CAGR of 11% between 2023 and 2028.
The global orthobiologics market was driven by the rise in hip and knee replacement cases in the historical period. Aided by increasing adoption of new procedures and rising geriatric population, the ...
The global prothrombin complex concentrate (PCC) market is being driven by the clinical advantage of PCC over fresh frozen plasma in the historical period. Aided by the widespread use of vitamin K ant...
The market for human insulin is expected to be driven by the growing demand from the North America region over the forecast period. This could be attributed to the rising incidence of diabetes and the...
Biosimilars refer to biologic products that have the same active properties as biologic drugs. They are integral in reducing healthcare costs and enhancing patient outcomes. Biosimilars are effective,...
The Europe biosimilar market attained a value of USD 4601.56 million in the year 2022 driven by the growing geriatric population in the region. Aided by the low cost of the product and the expected ex...
The global tumour necrosis factor inhibitor drugs market attained a value of USD 40.87 billion in 2022, driven by the increased incidences of different inflammatory diseases. Aided by the development ...
The global regenerative medicine market attained a value of USD 2.80 million in 2020 driven by the increasing number of clinical trials. Aided by technological advancements in biotechnology and nanote...
-
Aerospace and Defence
-
Agriculture and Farming
-
Animal Health and Nutrition
-
Automotive and Transportation
- Alternative Fuels
- Automotive Fluids and Lubricants
- Automotive Services
- Automotive Technology
- Automotive Tubes and Pipes
- Autonomous Vehicles
- Commercial Vehicles
- Electric and Hybrid Vehicles
- Luxury and Supercars
- Marine and Shipping
- Motorcycles and Scooters
- Parts, Components and Accessories
- Passenger Cars
- Recreational Vehicles
- Transportation and Logistics
-
Business and Finance
-
Chemicals and Materials
- Abrasives
- Catalysts
- Dyes and Pigments
- Fertilizers and Chemicals
- Flavours and Fragrances
- Industrial Gases
- Metals and Minerals
- Paints and Coatings
- Petrochemicals
- Plastics and Polymers
- Printing Inks
- Rubber and Elastomers
- Sealants and Adhesives
- Speciality and Fine chemicals
- Surfactants and Cleaning Chemicals
-
Construction and Infrastructure
-
Consumer Goods and Services
- Baby Care
- Bags
- Clothing
- Consumer Services
- Electronics
- Eyewear
- Foodservice
- Footwear
- Furniture
- Gems and Jewellery
- Gifts and Novelty
- Household Products and Accessories
- Luxury
- Office Products and Supplies
- Outdoor and Recreation
- Personal Care
- Pet Care
- Pet Food
- Retail and Consumer Goods
- Safety Equipment and Supplies
- Tobacco and Smoking
- Wellness
-
COVID Impact
- Aerospace and Defence
- Agriculture
- Animal Nutrition
- Automotive and Transportation
- Chemicals and Materials
- Construction and Building
- Energy and Power
- Engineering and Automation
- Financial Services
- Food and Beverages
- Goods and Services
- Health and Pharma
- Logistics and Supply Chain
- Retail and Manufacturing
- Technology and Media
- Trade and Investments
- Travel and Tourism
-
Electrical Equipment and Appliances
-
Energy and Power
-
Environment and Sustainability
-
Food and Beverages
- Additives and Ingredients
- Alcoholic Beverages
- Bakery
- Bottled Water
- Confectionery
- Dairy and Dairy Products
- Flour and Meals
- Food and Beverage Processing
- Food Testing
- Fruits and Vegetables
- Meat Products
- Non-Alcoholic Beverages
- Nutrition and Supplements
- Oils and Vinegars
- Packaged and Processed Foods
- Seafood
- Speciality Foods
- Sweeteners
- Vegetable Oils
-
Healthcare and Pharmaceuticals
-
Industrial Automation and Equipment
-
Logistics
-
Manufacturing
-
Packaging
-
Science and Technology
-
Technology, Media, and IT
NEWSLETTER